GERON CORP Logo

GERON CORP

A biopharma company developing a telomerase inhibitor for hematologic malignancies.

GERN | US

Overview

Corporate Details

ISIN(s):
US3741631036
LEI:
Country:
United States of America
Address:
919 EAST HILLSDALE BOULEVARD, 94404 FOSTER CITY

Description

Geron Corp is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for hematologic malignancies. Its lead product, imetelstat, is a first-in-class telomerase inhibitor approved for the treatment of certain blood cancers. The company's scientific approach targets telomerase to alter the course of hematologic myeloid malignancies, with the goal of extending and enhancing the lives of patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2018-05-10 18:15
CURRENT REPORT
English ZIP 29.7 KB
2018-05-10 18:01
10-Q
English ZIP 899.6 KB
2018-03-30 20:11
PRIMARY DOCUMENT
English ZIP 6.6 KB
2018-03-30 20:06
PRIMARY DOCUMENT
English ZIP 6.8 KB
2018-03-30 20:03
PRIMARY DOCUMENT
English ZIP 6.7 KB
2018-03-30 18:05
DEFA14A
English ZIP 259.0 KB
2018-03-30 18:01
DEF 14A
English ZIP 580.8 KB
2018-03-16 17:15
CURRENT REPORT
English ZIP 35.7 KB
2018-03-16 17:07
10-K
English ZIP 1.7 MB
2018-02-13 10:38 English ZIP 10.1 KB
2018-02-02 19:10
PRIMARY DOCUMENT
English ZIP 6.9 KB
2018-02-02 19:08
PRIMARY DOCUMENT
English ZIP 6.9 KB
2018-02-02 19:08
PRIMARY DOCUMENT
English ZIP 6.9 KB
2018-02-02 19:06
PRIMARY DOCUMENT
English ZIP 6.9 KB
2018-02-02 19:05
PRIMARY DOCUMENT
English ZIP 7.0 KB

Automate Your Workflow. Get a real-time feed of all GERON CORP filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GERON CORP

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GERON CORP via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alzinova AB Logo
Clinical-stage biopharma developing immunotherapies for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops and commercializes therapeutics to improve cardiovascular health.
United States of America
AMRN
AMGEN INC Logo
A biotechnology company developing human therapeutics for serious illnesses.
United States of America
AMGN
Industrial biotechnology company specializing in specialty enzymes and proteins.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Biotechnology company developing therapies for rare genetic and devastating diseases.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Specialty manufacturer of high-purity chiral amino acids and their derivatives.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops, manufactures, and distributes generic and specialty pharmaceuticals.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops, manufactures, and markets technically challenging medications.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Develops therapies for neurodegenerative diseases and other unmet medical needs.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Biopharmaceutical firm developing boron-based drugs for infectious diseases.
United States of America
ANTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.